Digraph

Klebsiella pneumoniae carbapenemase (KPC)
KPC-2
Klebsiella pneumoniae carbapenemase (KPC)
Keith Kaye, MD, MPH, on the Approval of Imipenem/Cilastatin + Relebactamhttps://www.contagionlive.com/publications/contagion/2019/december/keith-kaye-md-mph-on-the-approval-of-imipenemcilastatin--relebactam
2019-07 FDA approval of imipenem/cilastatin plus relebactamAmpC cephalosporinaseExtended spectrum beta-lactamases (ESBL)Klebsiella pneumoniae carbapenemase (KPC)
Keith S. Kaye, MD, MPH: RESTORE-IMI 2 and Treating Critically Ill Patients With Respiratory Infectionshttps://www.contagionlive.com/news/keith-s-kaye-md-mph-restoreimi-2-and-treating-critically-ill-patients-with-respiratory-infections
AcinetobacterAmikacinAmpC cephalosporinaseBacteremiaBacterial pneumoniaCefepimeCiprofloxacinEnterobacteriaceaeExtended spectrum beta-lactamases (ESBL)GentamicinImipenemImipenem-cilastatin-relebactamKlebsiella pneumoniae carbapenemase (KPC)LevofloxacinLinezolidMeropenemPiperacillin-tazobactamPseudomonasRelebactamSepsisTobramycinVancomycin

Showing topic

Klebsiella pneumoniae carbapenemase (KPC)
CarbapenemasesDrug-resistant Klebsiella pneumonia